• Author: Kathryn M. Pridgen
Clear all

Risk of systemic manifestations in homozygous carriers of the transthyretinV142I variant: A Million Veteran Program analysis

Abstract:Hereditary transthyretin amyloidosis is caused by pathogenic variants in the TTR gene, resulting in abnormal TTR (transthyretin) that deposits in organs. The c.424G>A …

Using natural language processing to extract carotid stenosis severity from clinical notes to create a nationwide Veteran cohort

Abstract:Objective: The prevalence of moderate to severe asymptomatic carotid stenosis (i.e., atherosclerotic narrowing of the extracranial carotid arteries) is generally ∼6% and …

Drug-gene interactions and clinical outcomes after vascular surgery in the Million Veteran Program

Abstract: IMPORTANCE: Pharmacogenetics can improve medication-related outcomes by optimizing efficacy and minimizing adverse effects. It is unknown whether the presence of …

Discovery of novel ancestry specific genes for androgens and hypogonadism in Million Veteran Program men

Abstract: Given the various roles of testosterone in men’s health, we conducted a multi-ancestral genetic analysis of total testosterone, free testosterone, SHBG, and …

Incorporating structured and unstructured data sources to identify and characterize hereditary cancer testing among Veterans with metastatic castration-resistant prostate cancer

Abstract: Purpose: This study introduces an integrated approach using structured and unstructured data from an electronic health record to identify and characterize patient …

Oral health, inflammation, and cardiometabolic factors in the VA Million Veteran Program

Abstract: Introduction: Associations between cardiometabolic comorbidities and self-reported oral health (OH) are often underexplored in large biobank datasets. While these …

Pharmacogenetic testing and monitoring of complete blood counts among Veterans newly prescribed thiopurine treatments: A retrospective cohort study

Abstract: Pharmacogenetic (PGx) testing before initiation of thiopurine treatment and CBC monitoring post-initiation helps avoid adverse events and ensure patient safety. This …